DOCGO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.05 USD | +3.74% |
|
-0.97% | -45.44% |
| May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
| May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 146 | 935.6 | 724 | 580.8 | 309.8 | - | - |
| Enterprise Value (EV) 2 | 146 | 935.6 | 724 | 554.5 | 217.2 | 156.9 | 91.76 |
| P/E ratio | -0.06 x | 37.4 x | 20.8 x | 93.2 x | 10.7 x | 13.6 x | 8.51 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 2.94 x | 1.64 x | 0.93 x | 0.49 x | 0.66 x | 0.71 x |
| EV / Revenue | - | 2.94 x | 1.64 x | 0.89 x | 0.34 x | 0.34 x | 0.21 x |
| EV / EBITDA | - | 37.3 x | 17.5 x | 10.3 x | 3.04 x | 2.87 x | 1.82 x |
| EV / FCF | - | -88,799,836 x | - | - | - | - | - |
| FCF Yield | - | -0% | - | - | - | - | - |
| Price to Book | - | - | - | 1.93 x | 0.93 x | 0.84 x | 0.72 x |
| Nbr of stocks (in thousands) | 14,375 | 100,069 | 102,411 | 103,896 | 101,566 | - | - |
| Reference price 3 | 37.30 | 34.34 | 25.96 | 20.53 | 11.20 | 11.20 | 11.20 |
| Announcement Date | 7/2/21 | 3/14/22 | 3/13/23 | 2/28/24 | - | - | - |
1AED in Million2USD in Million3AED
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 318.7 | 440.5 | 624.3 | 638.2 | 466.2 | 439.3 |
| EBITDA 1 | - | 25.1 | 41.3 | 54 | 71.55 | 54.7 | 50.48 |
| EBIT 1 | - | 15.36 | 21.83 | 15.05 | 36.76 | 33.93 | 20.6 |
| Operating Margin | - | 4.82% | 4.96% | 2.41% | 5.76% | 7.28% | 4.69% |
| Earnings before Tax (EBT) 1 | - | 19.8 | 22.78 | 16.29 | 36.67 | 27.14 | 19.1 |
| Net income 1 | -14.36 | 23.74 | 34.58 | 6.858 | 31.21 | 27.46 | 38.93 |
| Net margin | - | 7.45% | 7.85% | 1.1% | 4.89% | 5.89% | 8.86% |
| EPS 2 | -584.0 | 0.9182 | 1.249 | 0.2204 | 1.047 | 0.8265 | 1.317 |
| Free Cash Flow | - | -10.54 | - | - | - | - | - |
| FCF margin | - | -3.31% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 7/2/21 | 3/14/22 | 3/13/23 | 2/28/24 | - | - | - |
1USD in Million2AED
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 121.3 | 117.9 | 109.5 | 104.3 | 108.8 | 113 | 125.5 | 186.6 | 199.2 | 192.1 | 165.8 | 146.1 | 135.7 | 123.6 | 120.6 |
| EBITDA 1 | 17.3 | 13.6 | 12.3 | 8.4 | 6.8 | 5.6 | 9.1 | 16.7 | 22.6 | 24.1 | 17.51 | 15.54 | 15.42 | 15.63 | 14.37 |
| EBIT 1 | 15.45 | 10.09 | 7.458 | 4.199 | 0.0801 | -6.903 | 1.576 | 8.708 | 11.67 | 15.88 | 8.376 | 7.207 | 7.588 | 9.817 | 8.381 |
| Operating Margin | 12.74% | 8.56% | 6.81% | 4.03% | 0.07% | -6.11% | 1.26% | 4.67% | 5.86% | 8.26% | 5.05% | 4.93% | 5.59% | 7.94% | 6.95% |
| Earnings before Tax (EBT) 1 | 20.28 | 9.813 | 12.08 | 2.868 | -1.977 | -6.049 | 0.9886 | 9.157 | 12.2 | 15.72 | 8.474 | 7.324 | 7.699 | 9.985 | 8.551 |
| Net income 1 | 23.56 | 10.63 | 12.74 | 3.154 | 8.065 | -3.466 | -2.011 | 4.765 | 7.57 | 11.23 | 6.789 | 6.423 | 6.361 | 7.622 | 6.521 |
| Net margin | 19.42% | 9.02% | 11.63% | 3.02% | 7.41% | -3.07% | -1.6% | 2.55% | 3.8% | 5.84% | 4.1% | 4.39% | 4.69% | 6.17% | 5.41% |
| EPS 2 | 0.2204 | 0.3306 | 0.4041 | 0.1102 | 0.3673 | -0.1102 | -0.0735 | 0.1837 | 0.2571 | 0.3673 | 0.2357 | 0.2193 | 0.2188 | 0.2628 | 0.2132 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/14/22 | 5/9/22 | 8/8/22 | 11/7/22 | 3/13/23 | 5/8/23 | 8/7/23 | 11/6/23 | 2/28/24 | 5/8/24 | - | - | - | - | - |
1USD in Million2AED
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | - | - | 26.3 | 92.5 | 153 | 218 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | -10.5 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | 2.39% | 13.8% | 8.17% | 9.51% |
| ROA (Net income/ Total Assets) | - | - | - | 1.55% | 9.33% | 6.15% | 7.41% |
| Assets 1 | - | - | - | 442.5 | 334.5 | 446.2 | 525.3 |
| Book Value Per Share 2 | - | - | - | 10.60 | 12.00 | 13.40 | 15.60 |
| Cash Flow per Share 2 | - | - | - | - | 2.690 | 2.380 | 2.570 |
| Capex 1 | - | 4.81 | - | 7.58 | 6.3 | 6.93 | 7.62 |
| Capex / Sales | - | 1.51% | - | 1.21% | 0.99% | 1.49% | 1.74% |
| Announcement Date | 7/2/21 | 3/14/22 | 3/13/23 | 2/28/24 | - | - | - |
1USD in Million2AED
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
11.2
AED
Average target price
25.97
AED
Spread / Average Target
+131.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -45.44% | 310M | |
| +1.23% | 3.14B | |
| 0.00% | 1.94B | |
| +20.20% | 1.8B | |
| +68.75% | 706M | |
| -14.59% | 443M | |
| -11.38% | 191M | |
| -17.65% | 129M | |
| +3.85% | 69.12M |
- Stock Market
- Equities
- DCGO Stock
- Financials DocGo Inc.
